PolyPid PYPD
NASDAQ PYPD
$5.10 +0.02 (+0.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

PolyPid (PYPD) Accumulated Expenses (2019 - 2026)

PolyPid (PYPD) posted Accumulated Expenses of $3.6 million for Q1 2026, up 29.96% sequentially from $2.7 million in Q4 2025, and up 19.75% YoY from $3.0 million in Q1 2025.

PolyPid (PYPD) Accumulated Expenses (2019 - 2026) Analysis & Trends

PolyPid has reported Accumulated Expenses for 8 years, with the latest figure at $3.6 million in Q1 2026.

  • Quarterly Accumulated Expenses rose 19.75% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (up 19.75% YoY) and the FY2025 annual result came in at $2.7 million, up 6.55% from the prior year.
  • Accumulated Expenses improved to $3.6 million in Q1 2026 per PYPD's latest filing, from $2.7 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $4.1 million in Q2 2022 and troughed at $1.4 million in Q1 2023.
  • A 5-year average of $2.7 million and a median of $2.7 million in 2022 frame the typical range for Accumulated Expenses.
  • The sharpest annual moves came in 2023 and 2024: Accumulated Expenses sank 56.74% in 2023, then jumped 86.89% in 2024.
  • Over 5 years, Accumulated Expenses stood at $2.4 million in 2022, then decreased by 18.86% to $2.0 million in 2023, then surged by 30.19% to $2.6 million in 2024, then increased by 6.55% to $2.7 million in 2025, then advanced by 29.96% to $3.6 million in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $3.6 million, $2.7 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 PolyPid 113.86 Mn 107.09 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 3.65 Mn
Mar 31, 2026 3.55 Mn
Dec 31, 2025 2.73 Mn
Sep 30, 2025 2.21 Mn
Jun 30, 2025 2.97 Mn
Mar 31, 2025 2.97 Mn
Dec 31, 2024 2.57 Mn
Sep 30, 2024 2.77 Mn
Jun 30, 2024 2.98 Mn
Mar 31, 2024 2.61 Mn
Dec 31, 2023 1.97 Mn
Sep 30, 2023 2.02 Mn
Jun 30, 2023 1.84 Mn
Mar 31, 2023 1.40 Mn
Dec 31, 2022 2.43 Mn
Sep 30, 2022 2.72 Mn
Jun 30, 2022 4.11 Mn
Mar 31, 2022 3.23 Mn
Dec 31, 2021 3.94 Mn
Sep 30, 2021 3.49 Mn